Related Experiment Video
Updated: Feb 11, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
The association of CCL3 and CCL4 polymorphisms with HCV clearance in Chinese Han population
Mei Liu1, Ming Yue2, Yinan Yao1
1Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
Insights
Genetic variants in CCL3 and CCL4 influence hepatitis C virus (HCV) treatment outcomes. Specific SNPs (rs1063340 and rs1049807) were linked to reduced sustained virologic response (SVR) in patients undergoing interferon therapy.
Area of Science:
- Immunogenetics
- Virology
- Hepatology
Background:
- Hepatitis C virus (HCV) infection poses a significant global health challenge.
- Understanding host genetic factors influencing HCV clearance and treatment response is crucial for developing effective therapies.
- Chemokine ligand genes, CCL3 and CCL4, play roles in immune responses relevant to viral infections.
Purpose of the Study:
- To investigate the association between specific polymorphisms in CCL3 (rs1063340) and CCL4 (rs1049807) and HCV spontaneous clearance.
- To evaluate the impact of these CCL3 and CCL4 polymorphisms on sustained virologic response (SVR) to pegylated interferon-alpha and ribavirin (pegIFN-α/RBV) treatment.
Main Methods:
- Genotyping of two single nucleotide polymorphisms (SNPs), rs1063340 in CCL3 and rs1049807 in CCL4.
- Analysis of HCV clearance in a general population of 1585 untreated individuals.
- Assessment of SVR in a treatment cohort of 353 HCV patients receiving pegIFN-α/RBV therapy.
Main Results:
- No significant association was found between the studied SNPs and spontaneous HCV clearance.
- Variants rs1063340-C and rs1049807-G in CCL3 and CCL4, respectively, were associated with a reduced likelihood of achieving SVR (P=0.026 and P=0.048).
- Ancestral alleles of both SNPs were linked to a 62% increased chance of viral clearance; glucose levels interacted with rs1063340's effect on SVR.
Conclusions:
- Genetic variations in CCL3 and CCL4 may serve as predictive markers for HCV treatment outcomes.
- These findings highlight the role of host genetics in modulating the response to antiviral therapy for HCV.
- Further research is warranted to elucidate the precise mechanisms linking these SNPs to HCV SVR.
Aim:
To explore the association of CCL3 (rs1063340) and CCL4 (rs1049807) polymorphisms with hepatitis C virus (HCV) clearance and sustained virologic response (SVR).
Methods:
Two populations were enrolled in the current study; one was a general population including 1585 untreated individuals, with HCV infection and the other was a treatment population comprising 353 HCV-infected patients treated with pegylated interferon-α and ribavirin (pegIFN-α/RBV). Two single nucleotide polymorphisms (SNPs) were genotyped, and the relationship between HCV clearance and treatment outcome was analysed.
Results:
The general population comprised 995 persistent HCV cases (both HCV RNA and anti-HCV were positive) and 590 spontaneous clearance cases (HCV RNA was negative, but anti-HCV was positive). An association between the SNPs and HCV clearance was not found in our study. The treatment population consisted of 235 patients who achieved SVR and 118 non-responders. Variants of both SNPs (rs1063340-C and rs1049807-G) were associated with a reduction in SVR following IFN treatment (dominant model: P = 0.026 for rs1063340 and P = 0.048 for rs1049807). In addition, the ancestral alleles of rs1063340 and rs1049807 increased the likelihood of virus clearance by 62% compared to both the derived and minor alleles of the two SNPs (P = 0.040).The interaction analysis showed that the level of glucose interacted with the association of rs1063340 and SVR.
Conclusions:
Our results suggested that genetic variants at the CCL3 and CCL4 loci may be marker SNPs for risk of HCV treatment outcome.
Related Concept Videos
Conservation of Small Populations
What is Population Genetics?
Population Growth
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
Most drugs undergo restrictive clearance, which is proportional to the...
Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Single Nucleotide Polymorphisms-SNPs

